510(k) K223722
K223722 is an FDA 510(k) premarket notification submitted by Mio Labs, Inc. for the device "MIO Blood Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on Jun 28, 2023. The device falls under product code NBW (System, Test, Blood Glucose, Over The Counter), a Class II device regulated under 21 CFR 862.1345.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 28, 2023
- Date Received
- Dec 12, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Test, Blood Glucose, Over The Counter
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for Mio Labs, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.